Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanodigmbio develops and commercializes high-quality targeted sequencing solutions including library prep kits and custom/canned gene panels. Their products are validated on major NGS platforms (Illumina/MGI), supporting precision medicine research in oncology, rare diseases, virology etc. They have established GMP manufacturing capabilities and serve both domestic Chinese and international markets. No clinical trial results as they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanodigmbio.